Skip to content
healthcare.dev

Tizanidine Hydrochloride

NDC 59651-315, Tizanidine Hydrochloride, capsule, from Aurobindo Pharma Limited.

Product NDC
59651-315
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213544
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59651-315 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
59651-315-7759651031577150 CAPSULE in 1 BOTTLE (59651-315-77)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/19cf46b5-d8dc-44cb-83d6-bacea0870dbe
  • NADAC price for package 59651031577

    GET /v1/drugs/nadac/59651031577

Use it

Look up 59651-315 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59651-315 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59651-315. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.